CULLINAN

Trademark usage description

pharmaceuticals; therapeutics; cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutics for the treatment of canc Read More

Classification Information

Class [005]
Pharmaceuticals; therapeutics; cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutics for the treatment of cancer and for use in the fields of oncology and immunology.

Classification kind code

Class [042]
Pharmaceutical research and development; scientific research and development; medical research and development; research and development services in the fields of drug discovery and oncology.

Classification kind code

Mark Details

Serial Number

2298812

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 14^th Dec 2024	Agent Changed
Submitted for opposition 256 on 14^th Oct 2024	Notification of Possible Opposition Sent
Submitted for opposition 135 on 25^th Jul 2024	Amendment to Application
Submitted for opposition 257 on 14^th Dec 2023	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 13^th Dec 2023	Formalized
Submitted for opposition 1 on 13^th Dec 2023	Created
Submitted for opposition 228 on 31^st Jul 2023	International Registration
Submitted for opposition 30 on 31^st Jul 2023	Filed

CULLINAN

Classification Information

Class [005]Pharmaceuticals; therapeutics; cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutics for the treatment of cancer and for use in the fields of oncology and immunology.

Classification kind code

Class [042]Pharmaceutical research and development; scientific research and development; medical research and development; research and development services in the fields of drug discovery and oncology.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals; therapeutics; cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutics for the treatment of cancer and for use in the fields of oncology and immunology.

Class [042]
Pharmaceutical research and development; scientific research and development; medical research and development; research and development services in the fields of drug discovery and oncology.